The gut metabolite imidazole propionate is a potential biomarker of and therapeutic target for atherosclerosis
Crossref DOI link: https://doi.org/10.1038/s41569-025-01200-8
Published Online: 2025-08-05
Published Print: 2025-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huynh, Karina
Text and Data Mining valid from 2025-08-05
Version of Record valid from 2025-08-05
Article History
First Online: 5 August 2025